Actavis' CEO, Sigurdur Oli Olafsson, was keynote speaker at the FT Global Pharmaceutical & Biotechnology Conference 2009, in London on 18 November.

In his presentation, "Transformation through collaboration - Increasing collaboration of originators & generics," he discussed his view of the future of an industry on the move, with generics and emerging markets in the midst of the growth strategy.

With its business model designed for constant improvement of cost efficiencies, he said, the generics industry is more recession proof than most.

Stefan Jokull Sveinsson, Actavis' EVP Research and development, was keynote speaker at the World Generic Medicines Congress Americas 2009, in Washington DC on 18 November.

He presented his views on the role of generic medicines in the provision of affordable and effective healthcare with topics including government initiatives to lower health cost and the role of generics in providing affordable medicine in a fiercly competitive environment with constant price erosion.